ASPS member surgeons Drs. Elise Min and Matthew talk about how GLP-1 weight loss can change the breasts.
Recap by typeshit. Post by American Society of Plastic Surgeons (ASPS) on X.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Industry estimates put a four-week supply near 150,000 won, below Mounjaro's 272,000 won, with launch possible before year-end pending approval.
His weekly medicine roundup lists Lilly's triple agonist results next to the optogenetics Nobel and an ARPA-H plan to speed drug development.
Loading…